Mala Murthy - Mar 19, 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
Mar 19, 2025
Transactions value $
-$173,416
Form type
4
Date filed
3/21/2025, 04:20 PM
Previous filing
Mar 4, 2025
Next filing
Apr 8, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +36.9K +36.95% 137K Mar 19, 2025 Direct F1
transaction TDOC Common Stock Sale -$173K -20.6K -15.04% $8.42 116K Mar 20, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -36.9K -33.33% $0.00 73.9K Mar 19, 2025 Common Stock 36.9K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3 One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.